ASX - By Stock
|
PSQ |
Re:
Ann: Results of Extraordinary General Meeting
|
|
ashtool
|
2 |
1.5K |
1 |
23/12/22 |
23/12/22 |
ASX - By Stock
|
2
|
1.5K
|
1
|
|
ASX - By Stock
|
PSQ |
Re:
Ann: Shareholder Update
|
|
ashtool
|
5 |
3.0K |
4 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
5
|
3.0K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp announces positive results of COVID-19 screening test
|
|
ashtool
|
530 |
152K |
2 |
23/03/22 |
23/03/22 |
ASX - By Stock
|
530
|
152K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp announces positive results of COVID-19 screening test
|
|
ashtool
|
530 |
152K |
2 |
23/03/22 |
23/03/22 |
ASX - By Stock
|
530
|
152K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp announces positive results of COVID-19 screening test
|
|
ashtool
|
530 |
152K |
2 |
23/03/22 |
23/03/22 |
ASX - By Stock
|
530
|
152K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp announces positive results of COVID-19 screening test
|
|
ashtool
|
530 |
152K |
1 |
23/03/22 |
23/03/22 |
ASX - By Stock
|
530
|
152K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp announces positive results of COVID-19 screening test
|
|
ashtool
|
530 |
152K |
1 |
23/03/22 |
23/03/22 |
ASX - By Stock
|
530
|
152K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp announces positive results of COVID-19 screening test
|
|
ashtool
|
530 |
152K |
2 |
23/03/22 |
23/03/22 |
ASX - By Stock
|
530
|
152K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp announces positive results of COVID-19 screening test
|
|
ashtool
|
530 |
152K |
2 |
23/03/22 |
23/03/22 |
ASX - By Stock
|
530
|
152K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp announces positive results of COVID-19 screening test
|
|
ashtool
|
530 |
152K |
1 |
23/03/22 |
23/03/22 |
ASX - By Stock
|
530
|
152K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp announces positive results of COVID-19 screening test
|
|
ashtool
|
530 |
152K |
4 |
23/03/22 |
23/03/22 |
ASX - By Stock
|
530
|
152K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: DurAVR First in Human Patient Study Follow Up
|
|
ashtool
|
57 |
20K |
17 |
04/01/22 |
04/01/22 |
ASX - By Stock
|
57
|
20K
|
17
|
|
ASX - By Stock
|
PPK |
Re:
Ann: Trading Halt
|
|
ashtool
|
20 |
6.1K |
0 |
18/05/21 |
18/05/21 |
ASX - By Stock
|
20
|
6.1K
|
0
|
|
Charts
|
CSL |
Re:
CSL possible pull back to low $200's
|
|
ashtool
|
582 |
339K |
3 |
15/12/20 |
15/12/20 |
Charts
|
582
|
339K
|
3
|
|
ASX - By Stock
|
PLS |
Re:
Ann: Trading Halt
|
|
ashtool
|
146 |
79K |
0 |
11/12/20 |
11/12/20 |
ASX - By Stock
|
146
|
79K
|
0
|
|
ASX - By Stock
|
CSL |
Re:
Why CSL is cheaper than you think
|
|
ashtool
|
7 |
4.1K |
1 |
20/08/20 |
20/08/20 |
ASX - By Stock
|
7
|
4.1K
|
1
|
|
ASX - By Stock
|
CSL |
Re:
Ann: CSL Results Announcement
|
|
ashtool
|
121 |
53K |
3 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
121
|
53K
|
3
|
|
ASX - By Stock
|
CSL |
Re:
Ann: CSL Results Announcement
|
|
ashtool
|
121 |
53K |
5 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
121
|
53K
|
5
|
|
ASX - By Stock
|
CSL |
Re:
incredible margins
|
|
ashtool
|
1 |
860 |
4 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
1
|
860
|
4
|
|
ASX - By Stock
|
CSL |
Re:
$ 34 million CSL stock traded in after market trade today
|
|
ashtool
|
36 |
17K |
3 |
18/08/20 |
18/08/20 |
ASX - By Stock
|
36
|
17K
|
3
|
|
ASX - By Stock
|
CSL |
Re:
buying csl before report or after?
|
|
ashtool
|
17 |
12K |
7 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
17
|
12K
|
7
|
|
ASX - By Stock
|
CSL |
Re:
Big sell call on CSL
|
|
ashtool
|
135 |
65K |
3 |
24/07/20 |
24/07/20 |
ASX - By Stock
|
135
|
65K
|
3
|
|
Charts
|
CSL |
Anti-Ageing
|
|
ashtool
|
3 |
2.4K |
5 |
20/06/20 |
20/06/20 |
Charts
|
3
|
2.4K
|
5
|
|
ASX - By Stock
|
KGN |
Re:
Ann: Trading Halt
|
|
ashtool
|
30 |
13K |
3 |
11/06/20 |
11/06/20 |
ASX - By Stock
|
30
|
13K
|
3
|
|
ASX - By Stock
|
CSL |
Re:
CSL has more downside...and chat
|
|
ashtool
|
614 |
241K |
0 |
27/05/20 |
27/05/20 |
ASX - By Stock
|
614
|
241K
|
0
|
|
ASX - By Stock
|
CSL |
Re:
News: CSL Australia's CSL to start work on immunoglobulin product to treat COVID-19
|
|
ashtool
|
4 |
3.0K |
2 |
19/05/20 |
19/05/20 |
ASX - By Stock
|
4
|
3.0K
|
2
|
|
ASX - By Stock
|
CSL |
Re:
CSL has more downside...and chat
|
|
ashtool
|
614 |
241K |
2 |
13/05/20 |
13/05/20 |
ASX - By Stock
|
614
|
241K
|
2
|
|
ASX - By Stock
|
CSL |
Re:
Ann: Company Update on COVID-19
|
|
ashtool
|
45 |
22K |
9 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
45
|
22K
|
9
|
|
ASX - By Stock
|
CSL |
Re:
Ann: Company Update on COVID-19
|
|
ashtool
|
21 |
8.4K |
1 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
21
|
8.4K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Chart predicting double prices
|
|
ashtool
|
75 |
38K |
1 |
17/01/20 |
17/01/20 |
ASX - By Stock
|
75
|
38K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Leading Global TAVR Expert Says ADAPT is a GAME CHANGER!
|
|
ashtool
|
43 |
25K |
7 |
28/11/19 |
28/11/19 |
ASX - By Stock
|
43
|
25K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Leading Global TAVR Expert Says ADAPT is a GAME CHANGER!
|
|
ashtool
|
43 |
25K |
4 |
28/11/19 |
28/11/19 |
ASX - By Stock
|
43
|
25K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Leading Global TAVR Expert Says ADAPT is a GAME CHANGER!
|
|
ashtool
|
43 |
25K |
14 |
28/11/19 |
28/11/19 |
ASX - By Stock
|
43
|
25K
|
14
|
|
ASX - By Stock
|
AVR |
Re:
Chart predicting double prices
|
|
ashtool
|
75 |
38K |
2 |
27/11/19 |
27/11/19 |
ASX - By Stock
|
75
|
38K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Chart predicting double prices
|
|
ashtool
|
75 |
38K |
3 |
26/11/19 |
26/11/19 |
ASX - By Stock
|
75
|
38K
|
3
|
|
ASX - By Stock
|
CSL |
Re:
Time to do a 5 for 1 split of csl shares
|
|
ashtool
|
71 |
63K |
1 |
11/11/19 |
11/11/19 |
ASX - By Stock
|
71
|
63K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
ashtool
|
152 |
88K |
6 |
31/10/19 |
31/10/19 |
ASX - By Stock
|
152
|
88K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
How Wayne Paterson has turned AHZ around....
|
|
ashtool
|
84 |
43K |
5 |
17/10/19 |
17/10/19 |
ASX - By Stock
|
84
|
43K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
ashtool
|
63 |
40K |
6 |
31/07/19 |
31/07/19 |
ASX - By Stock
|
63
|
40K
|
6
|
|
ASX - By Stock
|
RHC |
Re:
big jump
|
|
ashtool
|
8 |
6.9K |
1 |
20/05/19 |
20/05/19 |
ASX - By Stock
|
8
|
6.9K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: 2019 AGM Presentation
|
|
ashtool
|
97 |
43K |
11 |
14/05/19 |
14/05/19 |
ASX - By Stock
|
97
|
43K
|
11
|
|
ASX - By Stock
|
AVR |
Re:
Class action
|
|
ashtool
|
240 |
81K |
5 |
26/04/19 |
26/04/19 |
ASX - By Stock
|
240
|
81K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Class action
|
|
ashtool
|
240 |
81K |
9 |
25/04/19 |
25/04/19 |
ASX - By Stock
|
240
|
81K
|
9
|
|
ASX - By Stock
|
AVR |
TAVI & Edwards Lifesciences in the news
|
|
ashtool
|
1 |
1.2K |
7 |
05/04/19 |
05/04/19 |
ASX - By Stock
|
1
|
1.2K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
New analyst report from NDF Research
|
|
ashtool
|
18 |
10K |
7 |
20/03/19 |
20/03/19 |
ASX - By Stock
|
18
|
10K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
New WP interview
|
|
ashtool
|
10 |
57K |
3 |
19/03/19 |
19/03/19 |
ASX - By Stock
|
10
|
57K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Class action
|
|
ashtool
|
240 |
81K |
5 |
06/03/19 |
06/03/19 |
ASX - By Stock
|
240
|
81K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Class action
|
|
ashtool
|
240 |
81K |
7 |
06/03/19 |
06/03/19 |
ASX - By Stock
|
240
|
81K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Class action
|
|
ashtool
|
240 |
81K |
20 |
06/03/19 |
06/03/19 |
ASX - By Stock
|
240
|
81K
|
20
|
|
ASX - By Stock
|
AVR |
WP on the Radio
|
|
ashtool
|
21 |
9.5K |
8 |
26/02/19 |
26/02/19 |
ASX - By Stock
|
21
|
9.5K
|
8
|
|